Literature DB >> 16979844

Low-dose radiotherapy for Stage I seminoma--long-term results.

Marcus Niewald1, Johanna Freyd, Jochen Fleckenstein, Bernd Wullich, Christian Rübe.   

Abstract

PURPOSE: The aim of this study was to review retrospectively the results of low-dose radiotherapy for Stage I seminoma using four different fractionation schedules and target volume definitions. METHODS AND MATERIALS: A total of 191 patients underwent irradiation for histologically proven Stage I seminoma after undergoing an inguinal orchiectomy. Fractionation schedules were used one after another as follows: Total dose 30 Gy (dose/fraction 1.5 Gy, 16 patients), total dose 25.5 Gy (dose/fraction 1.5 Gy, 62 patients), total dose 20 Gy (dose/fraction 2 Gy, 69 patients), total dose 26 Gy (dose/fraction 2 Gy, 29 patients). The remaining 12 patients were excluded from this study. In the same period the target volume was gradually reduced. In 1983 the paraaortic, pelvic and inguinal regions were irradiated; later the target volume was reduced to the paraaortic region exclusively.
RESULTS: Overall survival and event-free survival were identical in all groups ranging from 95% to 100% /5 years. Three patients experienced a lymph node metastasis during follow-up, 3 patients a distant metastasis to the lung and the bones. Mild acute side effects were noted in 8% to 15% of the patients, and very mild long-term side effects in 1% to 5% of patients. Multivariate analysis showed no prognostic significance of total dose, dose per fraction, or target volume. In univariate analysis, a higher frequency of acute side effects to the skin and the bowel was related to a higher total dose, and an elevated frequency of nausea was related to a higher daily dose per fraction.
CONCLUSION: Using lower doses and limiting the target volume to the paraaortic region exclusively did not result in a worse prognosis in our patient series.

Entities:  

Mesh:

Year:  2006        PMID: 16979844     DOI: 10.1016/j.ijrobp.2006.06.054

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

Review 1.  Controversies in the management of early-stage germ cell tumors.

Authors:  Ann Tan; Timothy Gilligan
Journal:  Curr Oncol Rep       Date:  2009-05       Impact factor: 5.075

2.  Stage I seminoma: treatment outcome at King Hussein Cancer Center in Jordan.

Authors:  Jamal Khader; Ahmed Salem; Yazan Abuodeh; Abdelateif Almousa; Naim Farah; Fadwa Abdelrahman
Journal:  BMC Urol       Date:  2012-04-24       Impact factor: 2.264

3.  Treatment of stage I seminoma: 25 years of experience.

Authors:  Małgorzata Pilichowska; Piotr Pęczkowski; Dorota Rosińska-Okrasa; Barbara Trzaska; Anna Skowrońska-Gardas; Tomasz Demkow
Journal:  Contemp Oncol (Pozn)       Date:  2012-05-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.